Healthcare Companies Worldwide

If you are looking for the best Endocrinologist in Warangal, then we are the best option for you. Our team will provide you quality solutions. To learn more, visit our website.

Renew Neurotherapy is a therapy company. We provide counselling (talk therapy, psychotherapy), body and brain calming techniques (neurofeedback and yoga therapy), therapy to help manage insomnia and sleep disorders, teach life skills, and provide brain injury rehabilitation. We have psychotherapists, occupational therapists, and rehabilitation assistants and neurofeedback associates.We see clients online and in person (in Ottawa, Pembroke and North Bay, Ontario, Canada).

Phone - (613) 809 1770

Email - info@renewneurotherapy.com

Website - https://renewneurotherapy.com/

CEIBA Tele ICU is the 1st Tele ICU company in Turkey and we are Pioneer for Tele Intensive Care Unit Technologies and services in Turkey and near geographies. We are dedicated to improving critical care, helping to save patient lives who needs critical care and improving the lifestyles of bedside providers. We use evidence-based practices, smart technologies such as IoT and AI in developing our cutting edge Tele ICU platform. Our experienced intensivists and RNs serve on 24/7 basis attention to dramatically improve care and aim to change the standards in the industry.

Over 10 million people around the world are suffering with stiffness and slowness caused by Parkinson’s Disease. CUE1, a focused vibrotactile stimulation device, has granted all of the pilot participants improved movement. Participants claimed that they felt their movement was smoother and better coordinated when using the device.

Charles helps men regain control over their daily health concerns by starting with their personal health.

DoctorValley is India's leading medical tourism company that takes care of everything you need for a simple and stress-free stay during your medical visit to India. With a group of enthusiastic, hardworking and committed individuals. We aim to help people looking for safe, high quality and affordable healthcare options in India. We stand proudly with our goal of providing the best healthcare at reasonable prices. We at DoctorValley appreciate the opportunity you have given us to help you achieve a better and healthier lifestyle.

Our specialized Treatments

• Cancer treatment
• Cardiology treatment
• Orthopaedic treatment
• ENT treatment
• Neuro treatment
• Organ transplant treatment
• Bone marrow transplant
• Bariatric Surgery and Weight Loss Surgery in India
• Neuro and Spine Surgery in India

Address / Location:
Bangalore (Headquarters)
#63,1st floor,industrial layout,
5th Block, Koramangala,
Bangalore- 560095

Phone: +91-7975350894

Email: info@doctorvalley.com

Website: https://www.doctorvalley.com

Science-enabled Precision Oncology

We’re 4 MIT engineers who started Encora to research wearable solutions for patients with movement disorders. We’re leveraging advances in wearable technology, signal processing, reinforcement learning, and patient sensing to provide affordable, personalized, non-invasive remedies for patients with neurological movement disorders. As part of the PD community, we're also raising awareness for #parkinsons!

Helppy is a CareTech 👵🏻 company providing Europe's most modern home care. We're currently operating in 🇫🇮Finland, 🇩🇪Germany and 🇫🇷France. We have made home care transparent and family-friendly, starting from our founder Richard’s need for his own mother. We're a registered provider in each country and customers can use many public-pay reimbusements to pay for our service. We’re backed by leading Nordic VC funds Alliance and Icebreaker as well as three superstar angels, whom all founded their own unicorns, namely: Johannes Schildt (Co-Founder & CEO of KRY, Europe's leading remote healthcare provider), Elias Aalto (Co-Founder of Wolt, a leading home delivery platform) and Yury Yakubchyk (Founder & CEO of Elemey, fastest growing US healthcare startup providing autism home care). Compared to traditional home care, we offer 10x more visits from the same familiar helpper/nurse, 3x more needs from a single-point-of-contact and a step change in peace of mind via our transparent Family portal. Our freemium Family portal is great and simple way to start organizing all for your aging parent. We’re on to a fast start, with almost 100% customer retention and satisfaction. We launched in Helsinki and quickly expanded nationwide in Finland. Now, we’re aiming at launching in several European countries. Follow us and join our team. The elderly care industry is about to change! www.helppy.com www.helppy.de www.helppy.fi www.helppy.com/fr www.helppy.com/en/careers

HomeDoctor is a brand new service for Patient’s, enabling to book Doctor’s appointment at home via an app with geolocation, thanks to which Patient gets: 1. SPEED – Doctor’s visit in up to 60 min from request 2. CONVENIENCE - Doctor's visit in the comfort of your home, office or hotel 3. VALUE FOR MONEY - prices starting from 169 zł Service available in Warsaw, Wrocław, Tricity Don't get the flu while waiting for Doctor’s appointment or free slot in medical center. Don't get sicker in the waiting room. Stay in your best health in the comfort of your own home, office or hotel

Hospimedia gives you the keys to understanding the workings of the health sector and medico-social.

We are a leading European healthtech enabler to industry and government. We provide enterprise software to hospitals, clinical research organizations, and pharmaceutical companies, who would like to build virtual data networks that aggregate health Big Data with one tool to support clinical trials, observational studies, real world evidence (RWE), population health analytics, and pandemic monitoring.

Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.

Docly is enabling clinicians to provide digital healthcare 24/7. We are proud of being a spin-off from the pioneering digital health care provider; Min Doktor established 2013. Docly was founded by a doctor and created for doctors. The strong partnership challenges Docly to push its limits and drive innovation in the industry of digital healthcare globally. Doclys´ "Time To Care" concept has contributed to more than 1,5 million consultations. Hence becoming a client of Docly automatically enables the client to be part of leading the development and change the way we care about people around the world. Today. And tomorrow.

Doctor.One is a next generation virtual clinic, helping any doctor build a subscription-based private practice. Our goal is to give everyone direct access to a private doctor, with the aim of restoring the trusted doctor-patient relationship as the foundation of healthcare. Doctor.One allows doctors to create and run a private medical practice in a subscription model. Unlike most telemedicine platforms, this virtual clinic is not centered around booking appointments. The cornerstone of the unique care model are daily "rounds", allowing physicians to respond directly to messages from their well-known patients or check on the progress of treatment. Using the mobile-first platform, the doctors can provide help via asynchronous chat, start a video call without revealing a private number or issue a prescription. If necessary, they can invite the patient to an in-person visit or make a house call. The continuous care model opens doors to more proactive medicine, with a private doctor monitoring a patient's health and addressing problems before they become more difficult and costly to treat. It’s a step towards more human, value-based healthcare. We care | We know how | We honor our word | We are one | We make a difference

At Doctrin, we are passionate about improving healthcare. We strive to make patients healthier and happier, and healthcare professionals more effective at work. We achieve this by providing digital tools automating and simplifying as much of the patient journey as possible, for as many patients as possible. The Doctrin team has diverse experiences in software development, healthcare provision and management consulting. All of us share the passion to improve healthcare and we are dedicated to build an organization with strong culture and values.

Doctrina is a young, ambitious enterprise with innovative online education solutions to provide pharmaceutical companies with a novel communication tools. Our pioneered solution is changing an approach within the business as pharmacists, pharmacy technicians and other healthcare professionals can further their knowledge about medicines and medical devices anywhere and anytime - 24 hours/day. This helps pharmaceutical companies reach higher and faster results with effective analytics and optimized investment in sales teams. By identifying and utilizing market potential, as a state-of-the-art solution provider, our aim is to become a global leader in online pharmaceutical products training and sales efficiency consulting. Our mission is to become a global education solution provider in the pharma industry. https://youtu.be/CxoNPJIRfyc

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument empowering doctors to see the first disease impacts. Our technology allows to visualize the morphology of many cells in the retina that are playing key roles in the disease degenerative process and that were invisible to ophthalmic instruments before. According to ophthalmologists, it will greatly improve the detection and monitoring of many diseases such as age-related macular degeneration. It will also provide quantitative evidence of treatment efficacy and speed up the development of new therapies. With EarlySight technology, assessing the retina state of health and monitoring treatment effects can be done non-invasively in only few seconds, without having to wait months for visual acuity changes.

#EasyWeek is an easy-to-manage online #appointment #scheduler made to automate your business from the service industry.

Suns Care offers sunscreen products.

Problems that occure after open abdominal surgery are both painful and difficult for clincians and patients. Scientific evidence shows that the right surgical technique can reduce complications after open surgical procedures. Research shows that it is essential to follow best practice and clinical guidelines to reduce the risk of complications, such as incisional hernia and deep wound infections. Today more than 20% of patients develops hernia after abdominal surgery. We at Suturion want to be part of preventing these unnecessary complications by assisting clinicians with technologies to adhere to best practice prinicples of abdominal closure. During training and practice surgeon Gabriel Börner often encountered complications to closure of the abdomen after surgery. Most notably wound infections and incisional hernias. This experience, together with a growing body of scientific evidence and research showing that a evidence-based surgical technique can reduce these complications planted an idea that a device could help surgeons prevent hernias instead of repairing them. Suturion AB was founded in 2018 by Gabriel Börner and medtech engineer Mats O. Christensson and LU Holding AB. Suturion have during the last years filed several patent applications, performed extensive market analysis and pre-clinical reserach. Gabriel Börner MD is a frequent speaker at medical congresses and travels the world presenting his scientific research and findings. During 2022 Suturion are conducting a clinical trial which is an important step toward the regulatory pathway for CE and FDA approval.

At 52North, we are reinventing the healthcare journey. We are doing this by developing fully-integrated clinical, AI and medical-device based systems to improve healthcare delivery and quality of life. We create affordable technologies that empower people and enable decentralised clinical decision-making. We prioritise human-centred design and engage with people living with disease throughout our product life-cycle to reinvent their healthcare journeys.

AI-powered precision diagnostics for pathology

AI Metrics brings innovative imaging software to the radiology market, powered by creative thinking, deep expertise in clinical and research environments, and a passion for crafting the tools radiologists need today to read studies faster, with higher accuracy, vastly reduced variability between studies, and robust (data centered) output.

Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. We use our novel, proprietary discovery platform to select and develop highly specific peptide-based therapies, known as “apitopes®”, which restore the natural balance (immune tolerance) of the immune system. This mechanism of action avoids global immune suppression and has the broad potential to treat a wide variety of autoimmune diseases. Apitope’s lead product candidate ATX-MS-1467 is in clinical development for treating multiple sclerosis (“MS”). ATX-MS-1467 is the first potential therapeutic for MS that combines high efficacy with an excellent, and thereby differentiating, safety profile. Apitope’s other lead product candidate ATX-GD-59 demonstrates potential to be the first disease-modifying treatment for Graves' disease and the first potential innovative treatment for the disease in more than 60 years. In addition, Apitope has developed a robust pipeline with several innovative, potential first-in-class product candidates advancing towards clinical development for the treatment of, amongst other indications, uveitis, factor VIII inhibitors, myocarditis, and rheumatoid arthritis. Founded in 2002, Apitope has an experienced leadership team with a strong track record in the pharmaceutical industry and scientific community.

In 2016, Rebecca Taylor – Aquarate's founder and design engineer – set out to redefine the pathway for hydration in healthcare settings. The start up is developing revolutionary technology for a suite of products that will enable individuals to manage their own hydration. This allows health care professionals to have accurate real time data when they need it. In May 2017 Aquarate co-founded with Nova and Deepbridge capital. The multi-disciplinary team being utilized, are united about a common goal: to reduce hydration related illness and improve human health.

Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following the acquisition of all rights to our lead product from subsequent shareholder, Ipsen. Headquartered in Berlin, Ariceum has operations in Germany and is active across Europe, North America and Australia.

Biofidelity's mission is to enable the early detection of disease and to improve patient outcomes through the implementation of simple yet ultra-high sensitivity diagnostic assays based on our proprietary biochemistry. We have developed a novel molecular assay enabling the multiplexed detection of genetic mutations at extremely high sensitivity (<0.1% allele fraction) from tissue or blood samples, without the need for DNA sequencing. Using standard laboratory instrumentation, our assays are simple, fast, scalable and low-cost, enabling rapid implementation and broad adoption. The simplicity of this technology makes it particularly suited to routine testing applications, including patient monitoring for disease recurrence and developed resistance to therapy, and to early detection of disease.

IntelliProve is a fast growing MedTech start-up based in Ghent, Belgium. The company is developing a computer technology capable of accurately determining health parameters within a few seconds, based on an optical measurement of the face. A combination of novel signal processing and computer vision technology is at the heart of IntelliProve's technology. IntelliProve measures physiological and mental health parameters with one click on a smartphone. All within the healthcare platform. - fast - contactless - no hardware - seamlessly integrated Connect to IntelliProve’s API and power up your healthcare platform or app with the future of biomarker technology. Deliver quantitative and real-time health insights to your users! Find out more about IntelliProve on the website! https://www.intelliprove.com/

Healz develops software to measure and analyze your metabolic condition using glucose monitoring, hormonal science and diagnostic AI.

1001Pharmacies is a French drugstore that sells personal health and well-being products online.

Makers of Simulation Technology. Bridging the gap between human knowledge and machine power.

Your riding companion.

Coala Life (Nasdaq First North: COALA) is a Swedish medical technology and life science company focusing on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and the Coala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments. CE and FDA cleared. We make it possible for everyone to monitor their heart. Cardiovascular diseases are one of the leading causes of death around the world. A key contributor is late diagnosis. Coala Life was founded as a research project in 2004 and physicians and Swedish researchers to change that. In 2015, Coala Life was formed as a company and the solutions are here that replace an analogue device from the 18th century, the stethoscope, with a digital solution that records both heart sounds, ECG, and heart frequency. A unique solution that listens, measures and analyses heart data with smart algorithms, which allows many heart diseases to be detected and treated early. A series of patents and unique technology is the base this unique Swedish system. www.coalalife.com

Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen.

AioCare by Healthup | Personal system to monitor and treat pulmonary diseases, consisting of a portable spirometer connected to a smartphone app and a dedicated doctor’s panel for remote tracking of your results and secure communication.

Albert is an evidence-based multi-chronic disease management platform that leverages AI.

Timeline (parent company Amazentis) is an innovative, dynamic and growing biotech company positioned in the nutrition and skin health sectors and is located in the multicultural region of Lausanne, Switzerland. Acting at the intersection of the food and pharma industries, Amazentis employs best-in-class science to discover and develop new products to increase longevity, manage specific health needs, and support an active lifestyle.

Ambler is an intermediation platform that connects health care prescribers to ambulance companies.

Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.

Biolux Medical is biotechnology company that specializes in photomodulation.

Our purpose is to redefine the cannabis industry and craft a new episode in its history. Our vision is to become the No 1. brand ecosphere in the recreational cannabis sector. We are convinced that it’s time to switch lanes & move cannabis beyond its sole purpose as an ailment-relief treatment for patients. We believe in cannabis as a statement by people who dare to tap into themselves & live an elevated, modern and community-driven life.

Bokadirekt is an online booking provider and marketplace for primarily the health and beauty sector.

1000Farmacie brings thousands of pharmacies online with minimal efforts. Through our technology, we integrate with pharma retailers and allow them to sell online.

EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases

At EvoAId we are working along 3 mission statements. We are data driven, multisectoral and socially responsible. The best framework for our missions to be achieved is the smart city where loads of information including images, texts, and time-varying data is generated. To process and handle this data synergistically we have built a comprehensive IT infrastructure which consists of AI based computer vision, natural language processing and sequential data analysis and the dedicated software and hardware environment. Our innovative solutions address the action fields of smart living, mobility and economy. Guarding Beats addresses the smart living action field, within that the safety and care especially for elderly. It offers affordable way of fall detection with higher accuracy and requires a smartphone only. Tracking Vibe addresses the field of smart mobility and offers edge computing for Real-Time road quality and defect detection and co2 concentration logging and mapping system. Accounting Swish addresses the smart economy field and offers automated solutions for document processing and payroll based on Hungarian regulation. EvoAId is involved in a international R&D which is being realized in an international consortium with Hugarian, Austrian and Portugal institutions. https://aph-alarm-project.com/index.php/en/

Amber Implants is a medical technology company located in The Netherlands. At Amber Implants, we design advanced spinal implants with porous structures using Additive Manufacturing (AM) technology. Currently, we are developing our first product VCFix: the new generation and only cementless treatment of patients with vertebral compression fracture. We are currently undergoing preclinical validation and will start our clinical trials in 2022. Connect with us now to partner, for career opportunities or to hear about our progress! CAUTION Investigational device. Limited by Federal law to investigational use.

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical candidate from Crescendo’s T cell enhancing pipeline. Crescendo is also developing CB213, a preclinical PD-1 x LAG-3 multi-specific Humabody. The Company’s ability to develop multi-functional Humabody therapeutics is based on its unique, patent protected, transgenic mouse platform generating fully human VH domain building blocks (Humabody VH). These robust molecules can be configured to engage therapeutic targets in such a way that they deliver novel pharmacology and superior bio-distribution. This can lead to larger therapeutic windows compared to conventional IgG approaches. Humabody-based formats can also be applied across a range of non-cancer indications. Beyond Crescendo’s proprietary pipeline, the Company has global, multi-target discovery and development collaborations with both Takeda and BioNTech and an exclusive, worldwide licensing agreement with Zai Lab for ZL-1102 (formerly CB001, an anti-IL-17A targeting Humabody), which is expected to enter global Phase 2 clinical development in patients with psoriasis. Crescendo Biologics is located in Cambridge, UK, and is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda and Quan Capital. For more information, please visit www.crescendobiologics.com.